AGP Executive Report
Last update: an hour agoCBD Product Transparency: CBDWatchlist.com launched a 2026 CBD Gummies and CBD Oil Transparency Review Initiative, pushing consumers to compare lab testing, labeling, ingredient lists, and refund/shipping terms before buying. Federal Rescheduling Watch: At the DEA’s marijuana rescheduling hearing, the federal government argued cannabis has accepted medical use, lower abuse potential, and less overdose risk than opioids and alcohol—while Michigan’s medical market continues to shrink as adult-use dominates. Virginia Retail Rollout: Virginia’s budget approved regulated recreational cannabis retail starting July 1, 2027, with up to 350 licenses, higher possession limits, and THC caps per serving and package. Industry Moves: Glass House Brands begins trading on the NYSE after medical cannabis reclassification to Schedule III, and TerrAscend signed an option to buy a fifth New Jersey dispensary. Hemp Policy Pressure: Wisconsin hemp supporters rallied against incoming federal limits on hemp products, warning many businesses could close in November. Public Safety Angle: Fresno police announced heavier DUI enforcement for the Fourth of July, stressing impairment can come from cannabis products too.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
